Cabergoline and cough Patient Reports February 12, 2012

Cabergoline Side Effects Report #5006744-5
Cabergoline side effect was reported by a Physician from GERMANY on May 03, 2006. Female patient, 69 years of age, was diagnosed with restless legs syndrome and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac failure, cough, pericardial effusion, pericarditis. Cabergoline dosage: unknown. Patient recovered.

Cabergoline Side Effects Report #5026989-8
Cabergoline side effect was reported by a Physician from GERMANY on May 30, 2006. Female patient, 69 years of age, weighting 147.7 lb, was diagnosed with restless legs syndrome and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac failure, cough, foreign body trauma, myocarditis, pericardial effusion, pericarditis, thyroid gland scan abnormal, viral infection . Cabergoline dosage: unknown. During the same period patient was treated with METOPROLOL SUCCINATE, CARVEDILOL. Patient recovered.

Cabergoline Side Effects Report #4644813-X
Cabergoline side effect was reported by a Physician from on Apr 11, 2005. Male patient, 48 years of age, weighting 183.0 lb, was diagnosed with restless legs syndrome and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cough, hyperhidrosis, influenza like illness, vomiting. Cabergoline dosage: 3 MG 1 MG, TID, ORAL. During the same period patient was treated with PANTOPRAZOLE. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #4634368-8
Cabergoline side effect was reported by a Physician from on Mar 28, 2005. Male patient, 84 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: agitation, cough, fatigue, loss of consciousness. Cabergoline dosage: 2 MG DAILY, ORAL; 4 MG DAILY ORAL; 0.5 MG DAILY, ORAL. During the same period patient was treated with MADOPAR, ENTACAPONE, CLOZAPINE. Patient died on 09/19/2004.


Cabergoline Side Effects Report #4656540-3
Cabergoline side effect was reported by a Physician from on Apr 22, 2005. Male patient, 84 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: agitation, cough, loss of consciousness. Cabergoline dosage: unknown. During the same period patient was treated with MADOPAR, ENTACAPONE, CLOZAPINE. Patient died on 09/19/2004.

Cabergoline Side Effects Report #4679992-1
Cabergoline side effect was reported by a Physician from on May 19, 2005. Male patient, 78 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cough, pleural effusion, pleurisy. Cabergoline dosage: unknown. During the same period patient was treated with DIOVAN, MENESIT, TOCOPHEROL. Patient recovered.

Cabergoline Side Effects Report #4846895-9
Cabergoline side effect was reported by a Physician from SWEDEN on Nov 24, 2005. Male patient, 73 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: atrial septal defect, cough, heart valve insufficiency, osteitis, pleurisy, prostate cancer , right ventricular failure, tricuspid valve disease, tricuspid valve incompetence. Cabergoline dosage: 0.5 MG DAILY ORAL. During the same period patient was treated with MADOPARK, REMERON, SINEMET, LEVODOPA, ELDEPRYL. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #4614167-3
Cabergoline side effect was reported by a Physician from on Mar 03, 2005. Female patient, 68 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cough, dyspnoea, interstitial lung disease, pleural effusion. Cabergoline dosage: 3 MG (1 MG, 1 IN 3 D), ORAL. During the same period patient was treated with MADOPAR, TALIPEXOLE HYDROCHLORIDE, AMANTADINE, SELEGILINE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #5102783-4
Cabergoline side effect was reported by a Consumer or non-health professional from DENMARK on Aug 28, 2006. Male patient, 56 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cough, dyspnoea, emphysema, increased upper airway secretion, interstitial lung disease, pleurisy, pulmonary fibrosis , pulmonary function test decreased. Cabergoline dosage: unknown. During the same period patient was treated with ELDEPRYL, REQUIP, SINEMET, COMTESS, SIFROL. Patient recovered.


Cabergoline Side Effects Report #5150533-8
Cabergoline side effect was reported by a Consumer or non-health professional from SWEDEN on Oct 26, 2006. Female patient, 35 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cough, dyspnoea, pleural fibrosis. Cabergoline dosage: unknown. Patient recovered.

Cabergoline Side Effects Report #4565809-2
Cabergoline side effect was reported by a Physician from on Jan 17, 2005. Female patient was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cough, dyspnoea, mitral valve incompetence, oedema. Cabergoline dosage: 8 MG, ORAL. During the same period patient was treated with ESTROGENS, MADOPAR. Patient recovered.

Cabergoline Side Effects Report #5022083-0
Cabergoline side effect was reported by a Consumer or non-health professional from AUSTRALIA on May 24, 2006. Male patient was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: bronchitis , cough, oxygen saturation decreased, procedural complication. Cabergoline dosage: (6 MG). During the same period patient was treated with ELDEPRYL, SINEMET, NEXIUM, QUINSUL, VALIUM. Patient recovered.